Come up with a name for your new list and we'll add to it:
Targazyme raised a round of funding on July 27, 2015. Investors include
National Cancer Institute.
Targazyme is a San Diego-based, clinical-stage biopharmaceutical company developing novel enzyme-based platform technologies and products to improve clinical efficacy outcomes for cell therapy, immuno…